SermorelinGHRH fragment
Sermorelin reproduces the active portion of growth hormone-releasing hormone. Its diagnostic and paediatric treatment history explains the mechanism, but does not establish a general adult rejuvenation benefit.
What is Sermorelin?
Sermorelin is a synthetic version of the first 29 amino acids of growth hormone-releasing hormone, or GHRH. Historical Geref products were used in growth-hormone testing and paediatric growth treatment.
How it works
It stimulates a functioning pituitary gland to release growth hormone. It does not supply growth hormone directly.
Effects studied
What does the evidence show?
Endocrine research and historical product records
A signal upstream of growth hormone
Sermorelin contains the first 29 amino acids of growth hormone-releasing hormone. It prompts a functioning pituitary gland to release growth hormone, rather than supplying growth hormone directly. This is why the condition of the pituitary and the reason for treatment matter to the response.
What the earlier medical use involved
The historical Geref products belonged to growth-hormone testing and paediatric growth treatment. Those contexts involve specific diagnostic questions and selected patients. They do not establish that an adult with fatigue, poor sleep or age-related changes has a condition that will improve when the same pathway is stimulated. 1 2 3
A hormone rise is only the first step
To establish a benefit in adults, a trial would need to compare physical function, symptoms or quality of life alongside adverse effects. A rise in GH or IGF-1 answers a biological question, but may not bring the improvement a person wants.
The preparation is part of the evidence
A compounded preparation does not automatically share the evidence or quality assessment of a historical product with the same ingredient name. Hormonal effects, fluid retention and glucose regulation also require attention. The exact diagnosis and intended outcome matter more than the fact that sermorelin has a history of medical use.
Safety & status
Fluid retention, changes in glucose regulation and other hormonal effects matter when evaluating repeated use. A compounded product does not automatically share the quality assessment of a historical medicine.
Country and product status
Product indications and availability vary by country; current EU and Swiss status has not been independently checked for this draft.
Frequently asked questions
Is sermorelin growth hormone?
No. It is a signal that prompts the pituitary to release growth hormone; the response depends on pituitary function.
Does its paediatric history prove an anti-ageing benefit?
No. Adult wellbeing and physical function require their own clinical outcomes, rather than simply a rise in GH or IGF-1.
Further reading
Sources
This entry was rewritten from our research archive. References below are reading leads unless a completed check is explicitly noted; a full independent evidence and regulatory review is still pending.
- Retained paper reference Archive research lead · Retained archive reference; not independently checked for this draft
- Retained paper reference Archive research lead · Retained archive reference; not independently checked for this draft
- Retained source reference Archive research lead · Retained archive reference; not independently checked for this draft
Research provenance
This name was discovered in the Superpower peptide index, archived 26 October 2026. Its ratings and reviewer attribution have not been adopted as our own. The archive informed this original editorial draft; independent source review is still pending.